Immatics (IMTX) had the highest return in 2018 by a US stock with a market cap of $500M+, returning 195,900%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Immatics (IMTX) | 2018 | 195,900% |
Tandem Diabetes Care (TNDM) | 2018 | 1,515.74% |
Semler Scientific (SMLR) | 2018 | 358.67% |
Xpel (XPEL) | 2018 | 326.68% |
Twilio (TWLO) | 2018 | 270.08% |
Caredx (CDNA) | 2018 | 240.19% |
Arrowhead Pharmaceuticals (ARWR) | 2018 | 236.59% |
Harrow Health (HROW) | 2018 | 234.71% |
Vericel Corp Ord (VCEL) | 2018 | 213.51% |
Tilray (TLRY) | 2018 | 206.03% |
American Superconductor (AMSC) | 2018 | 201.35% |
MongoDB (MDB) | 2018 | 179.79% |
Pacific Biosciences of California (PACB) | 2018 | 177.15% |
Trade Desk (TTD) | 2018 | 154.02% |
BlueLinx (BXC) | 2018 | 152.92% |
Okta (OKTA) | 2018 | 149.71% |
CorMedix (CRMD) | 2018 | 148.08% |
TKO (TKO) | 2018 | 144.83% |
KULR Technology (KULR) | 2018 | 136.36% |
PAR Technology (PAR) | 2018 | 132.62% |
Etsy (ETSY) | 2018 | 132.05% |
Xenon Pharmaceuticals (XENE) | 2018 | 125.36% |
Amedisys (AMED) | 2018 | 121.38% |
Goosehead Insurance (GSHD) | 2018 | 119.08% |
Glaukos (GKOS) | 2018 | 116.87% |
